CD4 and rheumatoid arthritis: Conversely, the low specificity of CD4+CD183+ for detecting RA observed in the present study further calls for the need for more studies of other potential biomarkers such as the possible biomedical applications of various nanostructures,37 in diagnostics and therapeutic approaches of RA.